Sunday 22 November 2026 Live: Iran war Stories Browse Wire Subscribe
Faultline Journal — home

IdeasAnalysis

A Gala for DIPG Research: Celebrity Giving and a Rare Childhood Tumour

The Cristian Rivera Foundation, founded after its namesake's death in 2009, has given more than $4 million to DIPG research and family support.

A Gala for DIPG Research: Celebrity Giving and a Rare Childhood Tumour

Reporting drawn from Times of India World. Analysis and editorial framing by the Faultline Journal Editorial Desk.

The gala is a fundraising event rather than a scientific milestone, and the report gives no figures for what the evening raised.

Kenan Thompson and Luis Guzman were among the hosts of the 17th Annual Cristian Rivera Foundation Celebrity Gala, held at Cipriani Wall Street in New York City on 10 November, according to the Times of India. NBC's Darlene Rodriguez also served as a host. The evening was organised to raise money for clinical trials, medical research and family support programmes, with a programme that included a red-carpet reception, dinner, an awards ceremony, live and silent auctions, and a video presentation on the experiences of affected children and families.

The foundation says it has donated more than $4 million towards research into diffuse intrinsic pontine glioma, or DIPG, a rare and aggressive childhood brain tumour, as well as financial assistance for affected families. Proceeds from the gala will support research and clinical trials led by Dr Mark Souweidane at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, along with research by Dr Oren Becher at Mount Sinai Kravis Children's Hospital. A portion of the funds will go towards direct financial assistance for families dealing with DIPG.

The organisation's origins lie in personal loss. Its founder, John "Gungie" Rivera, established the New Jersey-based nonprofit in 2009 after his son Cristian Alexander Rivera died of DIPG on 25 January 2009. According to the foundation's account, Cristian was diagnosed with an inoperable brain tumour on 22 January 2007, aged four, and was treated at Memorial Sloan Kettering and Weill Cornell Medical Center. The foundation says it has since become one of the country's major private financial supporters of DIPG research, and it also provides information, resources and monetary assistance to families.

In January 2026 the organisation announced a $365,000 donation to Weill Cornell Medicine, its largest single contribution to date. According to a January 8 report by Weill Cornell Medicine, Thompson joined Rivera in presenting the donation to Dr Souweidane, vice chair of the Department of Neurological Surgery and director of paediatric neurological surgery at NewYork-Presbyterian Komansky Children's Hospital. The money will support research into more effective, targeted treatments for children diagnosed with DIPG. A February 2026 report by Inside Philanthropy noted that the foundation had crossed the $4 million mark in cumulative donations towards DIPG research and family support.

The sums matter because DIPG is unusually hard to treat. The tumour grows in the pons, part of the brainstem responsible for breathing, heart rate and movement, and its location and tendency to spread into surrounding healthy tissue complicate treatment. According to the US National Cancer Institute, approximately 300 children are diagnosed with the condition in the United States each year, and most do not survive longer than two years. There is currently no established cure, which makes research into new treatment approaches and clinical trials particularly important.

The gala is a fundraising event rather than a scientific milestone, and the report gives no figures for what the evening raised. Nor does it establish how the new money will be allocated between the named research programmes and family assistance. What it does show is a privately funded research effort sustained by a single family's loss, and the dependence of rare-disease research on such philanthropy alongside public funding.

DIPGchildhood cancerphilanthropymedical researchNew York